{"product_id":"mirabegron-50mg-tablets-10s","title":"Mirabegron 50mg Tablets 10's","description":"\u003cp class=\"p1\"\u003e\u003cb\u003eMirabegron 50mg\u003c\/b\u003e is the maximum standard daily dose for adults prescribed to manage the chronic symptoms of an \u003cb\u003eoveractive bladder (OAB)\u003c\/b\u003e. By targeting beta-3 adrenergic receptors in the bladder wall, this extended-release medication relaxes the detrusor muscle. This therapeutic muscle relaxation expands the bladder's functional capacity, effectively reducing the frequency of wetting accidents, severe urinary leakage, and sudden, uncontrollable urges to urinate.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cb\u003eDosing and Administration\u003c\/b\u003e\u003c\/p\u003e\n\u003cul class=\"ul1\"\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eStandard Escalation\u003c\/b\u003e: Clinical guidelines advise starting OAB therapy at a 25mg dose. If a patient tolerates the initial dose well but requires greater symptom control, a physician may escalate the prescription to 50mg once daily after \u003cb\u003e4 to 8 weeks\u003c\/b\u003e.\u003c\/li\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eAdministration Rule\u003c\/b\u003e: The tablet must be swallowed whole with water and should \u003cb\u003enever be crushed, broken, or chewed\u003c\/b\u003e. Altering the tablet destroys its specialized extended-release matrix, which can cause the entire dose to enter the bloodstream too quickly, dangerously escalating the risk of severe side effects.\u003c\/li\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eTimeline for Relief\u003c\/b\u003e: Mirabegron 50mg is designed as a long-term maintenance treatment rather than an on-demand medication. It can take \u003cb\u003e8 weeks or longer\u003c\/b\u003e of uninterrupted daily use to achieve maximum clinical efficacy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p3\"\u003e\u003cb\u003eClinical Adjustments and Limits\u003c\/b\u003e\u003c\/p\u003e\n\u003ctable cellspacing=\"0\" cellpadding=\"0\" class=\"t1\" style=\"width: 99.9988%; height: 311.597px;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"height: 35.599px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 35.599px;\"\u003e\n\u003cp class=\"p4\"\u003e\u003cb\u003ePatient Population \/ Condition\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 35.599px;\"\u003e\n\u003cp class=\"p4\"\u003e\u003cb\u003eRecommended Mirabegron 50mg Guidance\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 55.1997px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eNormal Renal \u0026amp; Hepatic Function\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003eStandard maximum therapeutic maintenance dose (50mg once daily).\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 55.1997px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eSevere Kidney Disease\u003c\/b\u003e (eGFR 15–29 mL\/min)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eContraindicated at this strength.\u003c\/b\u003e The maximum daily allowance is capped at 25mg.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 55.1997px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eModerate Liver Impairment\u003c\/b\u003e (Child-Pugh B)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eContraindicated at this strength.\u003c\/b\u003e The maximum daily allowance is capped at 25mg.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 55.1997px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eSevere Hypertension\u003c\/b\u003e (Uncontrolled high blood pressure)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eStrictly contraindicated.\u003c\/b\u003e Must be avoided entirely due to risk of hypertensive crisis.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 55.1997px;\"\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 39.5839%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eCombination Therapy\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\" class=\"td1\" style=\"width: 59.8385%; height: 55.1997px;\"\u003e\n\u003cp class=\"p1\"\u003eCan be safely co-administered with \u003cb\u003esolifenacin 5mg\u003c\/b\u003e for patients refractory to monotherapy.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp class=\"p3\"\u003e \u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cb\u003ePrimary Side Effects \u0026amp; Precautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBecause it bypasses the central nervous system mechanisms targeted by older anticholinergic bladder drugs, mirabegron carries a significantly lower risk of causing severe dry mouth, constipation, or cognitive impairment. However, patients taking the 50mg strength should remain aware of specific physiological changes:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e“Mirabegron extended-release tablets can increase blood pressure... and are not recommended in patients with severe uncontrolled hypertension.”\u003c\/p\u003e\n\u003cul class=\"ul1\"\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eCardiovascular Monitoring\u003c\/b\u003e: Mirabegron can increase your heart rate and steadily elevate blood pressure. Routine blood pressure checks by a clinician are required during treatment. \u003c\/li\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eCommon Adverse Reactions\u003c\/b\u003e: The most frequently documented side effects include headaches, cold-like nasal symptoms (nasopharyngitis), mild nausea, or urinary tract infections (UTIs).\u003c\/li\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eUrinary Retention\u003c\/b\u003e: Patients with a pre-existing bladder outlet obstruction must use extreme caution, as severe muscle relaxation can occasionally result in an inability to pass urine normally.\u003c\/li\u003e\n\u003cli class=\"li1\"\u003e\n\u003cspan class=\"s2\"\u003e\u003c\/span\u003e\u003cb\u003eAngioedema\u003c\/b\u003e: In rare instances, life-threatening allergic reactions involving sudden swelling of the face, lips, tongue, or upper airway can occur, requiring immediate emergency medical intervention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003e\u003ci\u003eDisclaimer\u003c\/i\u003e\u003c\/b\u003e\u003ci\u003e: Always consult a licensed healthcare professional before initiating or modifying any prescription medication regimen. This information does not substitute for a formal clinical evaluation.\u003c\/i\u003e\u003c\/p\u003e","brand":"Optum Health Pharmacy","offers":[{"title":"Default Title","offer_id":53461319876908,"sku":null,"price":1320.0,"currency_code":"KES","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0844\/6895\/7484\/files\/prescription-required.png?v=1745497922","url":"https:\/\/optumhealthpharmacy.com\/products\/mirabegron-50mg-tablets-10s","provider":"Optum Health Pharmacy","version":"1.0","type":"link"}